tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Technical Analysis

Compare
1,411 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Ocular Therapeutix is a Buy.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 7.63, while Ocular Therapeutix’s (OCUL) share price is $7.25, making it a Sell.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 8.15, while Ocular Therapeutix’s (OCUL) share price is $7.25, making it a Sell.

Ocular Therapeutix (OCUL) Pivot Points

Feb 22, 2025, 04:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.01
7.09
7.23
7.31
7.46
7.54
7.68
Fibonacci
7.09
7.17
7.23
7.31
7.40
7.45
7.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

Feb 22, 2025, 04:22 AM
Period
Simple
Exponential
MA5
7.32Sell
7.33Sell
MA10
7.41Sell
7.43Sell
MA20
7.63Sell
7.63Sell
MA50
8.22Sell
8.15Sell
MA100
9.12Sell
8.50Sell
MA200
8.21Sell
8.18Sell
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 7.43, while Ocular Therapeutix’s (OCUL) share price is $7.25, making it a Sell.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 8.50, while Ocular Therapeutix’s (OCUL) share price is $7.25, making it a Sell.
Ocular Therapeutix’s (OCUL) stock price is $7.25 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 8.22, creating a Sell signal.
Ocular Therapeutix’s (OCUL) stock price is $7.25 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 9.12, creating a Sell signal.
Ocular Therapeutix’s (OCUL) stock price is $7.25 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 8.21, creating a Sell signal.

Ocular Therapeutix (OCUL) Technical Indicators

Feb 22, 2025, 04:22 AM
Name
Value
Implied Action
RSI (14)
36.19
Neutral
STOCH (9,6)
14.99
Buy
STOCHRSI (14)
11.68
Buy
MACD (12,26)
-0.28
Buy
ADX (14)
19.66
Buy
Williams %R
-90.60
Buy
CCI (14)
-103.73
Buy
ATR (14)
0.36
-
Ultimate Oscillator
40.93
Neutral
ROC
-6.81
Sell
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 36.19, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 19.66, creating a Buy signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is -103.73, creating a Buy signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is -6.81, creating a Sell signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Sell.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 36.19, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is -0.28, which suggests OCUL is a Buy.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 7.32, which suggests OCUL is a Sell.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 7.63, which suggests OCUL is a Sell.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 8.22, which suggests OCUL is a Sell.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 8.21, which suggests OCUL is a Sell.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -90.60, which suggests OCUL is a Buy.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is -103.73, which suggests OCUL is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis